Skip to main content
logo
Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
21.89
+0.76 (3.60%)
At close: Sep 2, 2026, 4:00 PM EDT
21.90
+0.01 (0.05%)
Pre-market: Sep 3, 2026, 4:24 AM EDT

Legend Biotech Revenue

Legend Biotech had revenue of $387.50M in the quarter ending June 30, 2026, with 51.90% growth. This brings the company's revenue in the last twelve months to $1.27B, up 59.54% year-over-year. In the year 2025, Legend Biotech had annual revenue of $1.03B with 64.02% growth.

Revenue (ttm)
$1.27B
Revenue Growth
+59.54%
P/S Ratio
3.34
Revenue / Employee
$428,803
Employees
2,965
Market Cap
4.24B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.03B401.60M64.02%
Dec 31, 2024627.30M342.20M120.03%
Dec 31, 2023285.10M168.10M143.66%
Dec 31, 2022117.01M48.18M70.00%
Dec 31, 202168.83M-6.17M-8.23%
Dec 31, 202075.00M15.02M25.04%
Dec 31, 201959.98M10.85M22.08%
Dec 31, 201849.13M25.54M108.24%
Dec 31, 201723.59M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Telix Pharmaceuticals890.79M
Iovance Biotherapeutics324.97M
IDEAYA Biosciences234.13M
Arcus Biosciences117.00M
Relay Therapeutics10.35M
Revenue Rankings

LEGN News

More News